El interés en corto de XTL Biopharmaceuticals da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de XTL Biopharmaceuticals. Los datos de interés en corto se actualizan cada dos semanas.

XTL Biopharmaceuticals (NASDAQ:XTLB) Bolsa, Informe de interés en corto

XTL Biopharmaceuticals

XTL Biopharmaceuticals Ltd is engaged in the development of therapeutics for the treatment of unmet medical needs. Its products include hCDR1 and Recombinant Human Erythropoietin (rHuEPO). hCDR1 is a Phase II-ready asset compound, working through a mechanism of action, for the treatment of Systemic Lupus Erythematosus (SLE) and Sjogren's syndrome. hCDR1 is a synthetic peptide that includes approximately 20 amino-acid residues. rHuEPO, a known agent for anemia, is being developed to prolong the survival of patients with advanced multiple myeloma (MM). rHuEPO is used in clinical practice for the treatment of various anemias, including anemia of kidney disease and cancer-related anemia.

XTL Biopharmaceuticals Ltd. - American Depositary Shares

XTL Biopharmaceuticals Ltd

MicroStrategy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>), a stock considered an alternative to Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) investment, received a bullish signal from moving average (MA) technical indicators.
What happened: According to the financial market analytics <a href="https://in.tradingview.com/symbols/NASDAQ-MSTR/technicals/">platform </a>TradingView, nearly all of the simple and exponential MAs flashed a &#8220;Buy&#8221; rating for the stock, culminating in a net &#8220;Strong Buy&#8221; signal.
Moving averages smooth out price data by creating a constantly updated average price. Typically, if the price is above a moving average, the trend is up. If the price is below a moving average, the trend is down.
On the contrary, momentum indicators painted a different story. The Moving Average Convergence Divergence (MACD) indicator, which compares a stock&#8217;s short-term price to its long-term price, flashed a ‘Sell' signal as of this writing.
Similarly, the Relative Strength Index (RSI) indicator used for spotting overbought or oversold conditions showed a ‘Neutral' reading for the stock.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41705004/peanut-the-squirrel-themed-meme-coins-surge-amid-social-media-outrage-over-celebrity-anima">Peanut The Squirrel-Themed Meme Coins Surge Amid Social Media Outrage Over Celebrity Animal&#8217;s Death</a>
The analysis of MicroStrategy's options trading market also exhibited a bearish sentiment.
The stock had a Put/Call Ratio of 1.2 as of this writing, according to the market analytics <a href="https://fintel.io/sopt/us/mstr">platform </a>Fintel, indicating that downside bets outnumbered bullish ones.
Why It Matters: MicroStrategy adopted Bitcoin as its primary reserve asset in August 2020, becoming the first publicly listed company to pursue this strategy.
Since then, it has gained 1989% in value, surpassing some of the biggest names on Wall Street, including artificial intelligence darling Nvidia Corp. The company's stock has outperformed the famed &#8220;Mag 7&#8221; group of companies in 2024, with year-to-date gains of 225%.
MicroStrategy holds about 252,220 BTCs, worth $17.37 billion, on its balance sheet, as per its <a href="https://www.benzinga.com/markets/cryptocurrency/24/10/41646462/michael-saylor-says-bitcoin-remedy-to-fix-unhealthy-balance-sheets-as-microstrategy-unveil">recently released third-quarter earnings report.&nbsp;</a>
The firm announced that it would raise $42 billion over the next three years through equity and debt financing to buy more Bitcoin.
Price Action: Shares of MicroStrategy were up 1.06% in after-hours trading after closing down 2.93% during Monday's regular session, <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a> showed.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41703454/analyst-says-this-crypto-could-explode-by-up-to-3-765-and-it-is-not-bitcoin-or-solana">Analyst Says This Crypto Could Explode By Up To 3.765%, And It Is Not Bitcoin Or Solana</a></li>
</ul>
Photo courtesy: MicroStrategy

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

News

Markets

$BTC

MSTR

Bitcoin Proxy MicroStrategy Gets 'Strong Buy' Signal From These Technical Indicators, But Here's Why You Should Be Mindful

"In collaboration with Broadcom, Telia is building a more agile, reliable and secure network and IT infrastructure to enable the delivery of new monetizable 5G and cloud services for the benefit of its customers in the Nordics and the Baltics," said Krish Prasad, SVP and general manager, VMware Cloud Foundation Division, Broadcom. "We are delighted to enable Telia to continue serving its customers with this VMware software-based platform that includes the needed network and infrastructure orchestration, automation and scale."

AVGO

Broadcom And Telia Strengthen Collaboration For Telco Transformation With Multi-Year VMware Cloud Foundation Expansion

Murtaza Ali, President of JazzCash, said: "We are proud to partner with BISP, the country's leading social protection programme, in the vital mission of alleviating poverty, and raising living standards, especially for women. We are committed to providing financial access to millions of underserved citizens. By offering affordable payment solutions and credit, JazzCash is playing a crucial role in bridging the financial inclusion gap across the country."

VEON

VEON's JazzCash Partners With BISP To Channel PKR 78B In Government Aid To Women, Boosting Financial Inclusion In Pakistan

Vanguard has surpassed BlackRock as the manager of the world&#8217;s second-largest ETF. 
What Happened: Vanguard&#8217;s S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VOO#NYSE">VOO</a>) has edged past BlackRock&#8217;s iShares Core S&amp;P 500 ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IVV#NYSE">IVV</a>) in terms of assets. As of last Friday, VOO held $540.76 billion, slightly exceeding IVV&#8217;s $540.66 billion, based on Morningstar data. This marks a notable change, as VOO was $58 billion behind IVV at the start of 2022, Financial Times<a href="https://www.ft.com/content/3067c4ce-8d0e-4307-8b1a-a7edd21639ff?ref=biztoc.com"> reported</a> on Tuesday.
VOO is now trailing the SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) by $50 billion, which remains the largest ETF globally. Analysts, including Bryan Armour from Morningstar, predict that VOO could surpass SPY by 2025 or 2026 if its current growth continues.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41734072/bitcoin-ethereum-slip-while-dogecoin-surges-ahead-of-presidential-election-analyst-predict?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum Slip While Dogecoin Surges Ahead Of Presidential Election; Analyst Predicts BTC Will Hi</a>
Vanguard&#8217;s broader S&amp;P 500 vehicle holds $1.28 trillion in assets, ranking as the second-largest investment fund globally. Meanwhile, the net assets held by BlackRock&#8217;s IVV ETF is $540.10 Billion. 
As per <a href="https://pro.benzinga.com">Benzinga Pro</a>, as of Monday, the net asset value (NAV) of year-to-date (YTD) returns of VOO has risen 21.10%. On the other hand, the NAV of YTD returns of IVV has been higher by&nbsp;21.43%. 
Both Vanguard and BlackRock&#8217;s ETFs charge an annual fee of 3 basis points, attracting retail investors. The ETF market has seen substantial growth, with assets exceeding $10 trillion in the U.S., nearly doubling over four years, according to ETFGI.
Why It Matters: The rise of Vanguard&#8217;s VOO reflects a broader trend of investors gravitating towards lower-cost ETFs. In May, a significant shift among major ETFs, with<a href="https://www.benzinga.com/markets/equities/24/05/38738050/investors-flock-to-lower-cost-vanguard-s-p-500-etf-is-it-time-to-switch-from-spy-to-voo"> SPY experiencing outflows</a> while VOO attracted new investments. This trend indicates a growing preference for cost-effective investment options among investors.
Additionally, in September, Vanguard&#8217;s ETFs<a href="https://www.benzinga.com/top-stories/24/09/41033617/voo-vs-vti-vanguards-s-p-500-total-stock-market-etfs-hit-new-highs-as-s-p-500-reaches-record-level"> reached new highs</a> as the S&amp;P 500 Index hit record levels, further solidifying Vanguard&#8217;s position in the market.
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41704760/bitcoin-ethereum-dogecoin-reverse-as-trumps-odds-fall-on-betting-markets-trader-says-bull-?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Bitcoin, Ethereum, Dogecoin Reverse As Trump&#8217;s Odds Fall On Betting Markets: Trader Says &#8216;Bull Run Will Begin&#8217; For This Crypto After The Election</a></li>
</ul>
Photo via Shutterstock
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Pooja-Rajkumari" target="_blank" rel="noreferrer noopener">Pooja Rajkumari</a>

ETFs

General

Vanguard Dethrones BlackRock As Second Largest ETF Manager: Here's How Their Funds With Exposure To S&P 500 Fared This Year

Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) remains a compelling investment opportunity despite increased infrastructure spending planned for the coming year, according to Bernstein analyst Mark Shmulik, who maintains an &#8220;Outperform&#8221; rating on the stock <a href="https://www.benzinga.com/markets/equities/24/11/41734887/cathie-woods-latest-shake-up-dumps-palantir-and-jack-dorseys-block-along-with-tesla-buys-amazon-">with a $235 price target</a>.
What Happened:&nbsp;&#8220;Amazon feels like the name that you can put money to work in and get excited about,&#8221; Shmulik <a href="https://x.com/YahooFinance/status/1853538096291225888">told</a> Yahoo Finance in a recent interview. The analyst highlighted several key factors supporting his optimistic outlook:
<ul>
<li>AWS revenue growth shows promising momentum heading into the fourth quarter.</li>
<li>Prime Video investments are strategically timed for the holiday shopping season.</li>
<li>Core business operations are &#8220;on solid footing and accelerating.&#8221;</li>
<li>The company is building the groundwork for &#8220;a very solid 2025&#8221; in terms of free cash flow.</li>
</ul>
While acknowledging increased infrastructure spending plans for the coming year, Shmulik emphasized that Amazon&#8217;s investments typically demonstrate good returns on investment, particularly in areas like Prime Video.
See Also: <a href="https://www.benzinga.com/markets/equities/24/11/41734875/palantirs-ai-gamble-pays-off-as-customer-revenue-from-single-customer-jumps-12x-in-under-8-month">Palantir&#8217;s AI Gamble Pays Off As Customer Revenue From Single Customer Jumps 12x In Under 8 Months</a>
Why It Matters: Amazon&#8217;s recent financial performance has been noteworthy. The company reported third-quarter net sales of $158.9 billion, an 11% increase year-over-year, surpassing the Street consensus estimate of $157.2 billion.
This strong performance has been a key driver of investor optimism. <a href="https://www.benzinga.com/news/earnings/24/10/41664778/amazon-q3-earnings-highlights-revenue-beat-eps-beat-q4-guidance-new-kindles-significantly-outperfor">Amazon&#8217;s third-quarter earnings</a> also included a positive outlook for the fourth quarter, with expected net sales ranging from $181.5 billion to $188.5 billion.
Additionally, analysts have highlighted the growth potential of AWS, which is in the early stages of a significant AI cycle. The advertising segment is also seen as a <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41692259/amazon-analysts-see-growth-ahead-with-aws-in-early-innings-of-a-big-ai-cycle-advert">fast-growing asset for Amazon</a>. 
Furthermore, Cathie Wood&#8216;s Ark Invest recently made significant trades, including <a href="https://www.benzinga.com/markets/equities/24/11/41734887/cathie-woods-latest-shake-up-dumps-palantir-and-jack-dorseys-block-along-with-tesla-buys-amazon-">buying Amazon shares</a>, reflecting confidence in the company&#8217;s growth trajectory. 
Price Action: The stock closed at $195.78 on Monday, down 1.09% for the day but up significantly year-to-date with a 30.58% gain. After-hours trading saw a slight decline of 0.34%,&nbsp;according to&nbsp;<a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41736493/microsoft-co-founder-bill-gates-says-everyone-in-future-will-have-a-utilitarian-ai-agent-that-will-h">Microsoft Co-Founder Bill Gates Says Everyone In Future Will Have A &#8216;Utilitarian AI Agent&#8217; That Will Help You At Work</a></li>
</ul>
Image Via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Analyst Color

Equities

Price Target

Reiteration

Tech

AMZN

Amazon Stock: Buy Now, Pay Off Later, Says Analyst

Earnings

IMOS

ChipMOS TECHNOLOGIES Q3 EPADS $0.26 Down From $0.50 YoY, Sales $191.70M Up From $176.24M YoY

<a href="https://www.nytimes.com/live/2024/11/04/us/harris-trump-election#f34c92c1-4cbb-5420-b457-285e740df675" title="https://www.nytimes.com/live/2024/11/04/us/harris-trump-election#f34c92c1-4cbb-5420-b457-285e740df675">https://www.nytimes.com/live/2024/11/04/us/harris-trump-election#f34c92c1-4cbb-5420-b457-285e740df675</a>

Harris Closes Campaign In Philadelphia, Trump In Michigan

<figure class="table"> 
<table>
<tbody>
<tr>
<td>FY24 GUIDANCE [1],[4]</td>
</tr>
</tbody>
</table>
</figure>
The outlook for FY24 reflects our current assessment of market conditions. Unless stated otherwise, guidance is on an adjusted comparable &amp; FX-neutral basis. Guidance is therefore provided on the basis that the acquisition of CCBPI occurred on 1 Jan 2023. FX is expected to be immaterial for the full-year.
Revenue : comparable growth of ~3.5% (previously ~4%)
• More balanced between volumes &amp; price/mix than FY23
• Two extra selling days in Q4
Cost of sales per UC: comparable growth of ~2.5% (previously ~3%)
• Expect broadly flat commodity inflation
• FY24 hedge coverage at &gt;95% (previously ~90%)
• Tax increase driven by Netherlands
• Concentrate directly linked to revenue per UC through incidence pricing
Operating profit: comparable growth of ~7%
Finance costs : weighted average cost of net debt of ~2%
Comparable effective tax rate: ~25%
Free cash flow: at least €1.7bn
Capital expenditure: ~5% of revenue excluding leases
Dividend payout ratio: ~50% [7] based on comparable EPS
Note: unless otherwise stated, guidance remains unchanged since the half year

Guidance

Coca-Cola European Partners plc Ordinary Shares

CCEP

Coca-Cola Europacific Q3 Revenue €5.358B (+2.4% YoY), Adjusted Comparable Volume +3.3%; Forecasts FY24 Revenues Comparable Growth Of ~3.5% (Prior ~4%)

Ford Motor Co.&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) electric vehicle sales in the U.S. dropped 8.3% in October following a drop in demand for its <a href="https://www.benzinga.com/topic/ford-f-150-lightning">F-150 Lightning EV pickup truck</a>.
What Happened: Ford sold 6,264 electric vehicles in October, with its Mustang Mach-E SUV accounting for a majority of sales. 
The company delivered 3,313 units of the electric SUV, marking a surge of about 21% from the corresponding month last year. F-150 Lightning sales, however, dropped by about 50% to 1,863 units, dragging overall EV sales lower. 
Sales of the E-Transit electric van, meanwhile, jumped 181%. 
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Model</td>
<td>U.S. Sales In October</td>
</tr>
<tr>
<td>Mustang Mach-E</td>
<td>3,313</td>
</tr>
<tr>
<td>F-150 Lightning</td>
<td>1,863</td>
</tr>
<tr>
<td>E-Transit</td>
<td>1,088</td>
</tr>
<tr>
<td>Total</td>
<td>6,264</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Source: Ford</figcaption></figure>
Despite the drop in EV sales, Ford&#8217;s overall vehicle sales soared over 15% last month to 172,756 units, owing to the rise in sales for both hybrid and internal combustion engine vehicles. Combustion engine vehicles accounted for about 86% of the company&#8217;s overall vehicle sales during the month. 
Why It Matters: Last week, Ford said that it would halt production of the F-150 Lightning for six weeks from <a href="https://www.benzinga.com/markets/equities/24/10/41661764/ford-to-halt-f-150-ev-production-for-7-weeks-next-month" target="_blank" rel="noreferrer noopener">Nov. 18 to Jan. 6</a>&nbsp;at the Rouge Electric Vehicle Plant.
&#8220;We continue to adjust production for an optimal mix of sales growth and profitability," a company spokesperson told <a href="https://pro.benzinga.com/dashboard">Benzinga</a> about the decision.
The Lightning pickup truck is up against Tesla's Cybertruck in the U.S. While Tesla sold 16,692 Cybertrucks in the third quarter, Ford sold only 7,162 units of the Lightning, according to data from<a href="https://www.benzinga.com/news/24/10/41325252/tesla-cybertruck-leads-the-pack-as-most-popular-ev-truck-in-us-in-q3-outselling-rivals-from-ford-gm" target="_blank" rel="noreferrer noopener">&nbsp;Kelley Blue Book</a>.
In August, Ford said that it is&nbsp;<a href="https://www.benzinga.com/top-stories/24/08/40496864/ford-scraps-electric-suv-as-it-adjusts-to-lower-electric-vehicle-demand" target="_blank" rel="noreferrer noopener">killing its plans to build a three-row electric SUV</a>, initially slated for production in 2025. The company also postponed its plans for a new electric version of its F-150 pickup to 2027 and said it will start making a new electric commercial van in 2026.
For the third quarter, Ford&#8217;s EV segment called &#8220;Model e&#8221; reported an EBIT (earnings before interest and taxes) loss of $1.2 billion after&nbsp;<a href="https://www.benzinga.com/news/24/10/41597865/fords-ev-segment-weighed-down-by-pricing-pressures-competition-ceo-jim-farley-points-out-very-aggres" target="_blank" rel="noreferrer noopener">cost improvements were offset by industrywide pricing pressure</a>, taking its loss this year through the end of September to $3.7 billion. The company now expects a full-year EBIT loss of $5 billion from the segment.
Price Action: Ford shares closed up by about 1.4% on Monday at $10.36. The stock is down by about 14.8% year-to-date, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>. 
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41709658/stephen-king-slams-elon-musk-claims-most-of-his-posts-spread-pro-trump-disinformation-and-outright-l">Stephen King Slams Elon Musk, Claims Most Of His Posts Spread &#8216;Pro-Trump Disinformation And Outright Lies&#8217;</a></li>
</ul>
Photo courtesy: Shutterstock

Ford EV Sales Drop Over 8% In October As Demand For F-150 Lightning Slows Down

Contracts

ESLT

Elbit Systems Awarded Follow-On $127M Contract For Iron Fist APS, Supporting Bradley IFV Upgrades Over 34-Month Period

<ul>
<li>During the month of October, the Company mined 46 Bitcoin ("BTC"), or 1.5 BTC per day, a 24% increase over the Company's September production.</li>
<li>Mining revenue in October 2024 amounted to $3.0 million up 36% from $2.2 million in September 2024. The increase in mining revenue reflects increased uptime as a result of lower power costs compared to September and the stronger hashprice realized during the month of October. As at 31 October 2024, the Company held two BTC equivalent.</li>
</ul>

ARBK

Argo Blockchain Reports Bitcoin Mining Revenue Of $3M For October 2024 Up From $2.2M In September 2024

<ul>
<li>Evotec divests chemical API-focused CDMO operation in Halle/Westphalia (Evotec DS) to Monacum Partners</li>
<li>Transaction aligns with Evotec's strategic optimization efforts, concentrating resources on key growth drivers</li>
<li>New ownership committed to maintaining and growing the business</li>
</ul>

Evotec Divests API Manufacturing Site To Monacum Partners As Part Of Strategic Focus Shift; Terms Not Disclosed

Microsoft co&#8211;founder Bill Gates has shared his insights on the future of workplace efficiency, emphasizing the transformative role of AI agents. In a conversation with Reid Hoffman and Aria Finger during Wednesday&#8217;s episode of &#8220;Possible&#8221; podcast, Gates highlighted that AI will drastically change task execution.
What Happened: Gates elaborated on AI&#8217;s potential to handle complex tasks, particularly in white-collar sectors, surpassing initial expectations. He noted the surprising sequence in which AI has affected job types, with the automation of white-collar tasks preceding that of blue-collar ones. Gates foresees AI robots performing tasks at construction sites and hotels within a decade.
Reflecting on his original vision of a PC on every desk, Gates predicted that AI would extend this concept. He envisions natural language becoming the primary programming language, enabling everyone to have a coding assistant. This shift will allow for more efficient data navigation and business operations without needing custom software.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Bill Gates on possibility, AI, and humanity" width="500" height="281" src="https://www.youtube.com/embed/KeGYI69sWvw?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
See Also: <a href="https://www.benzinga.com/news/24/11/41702294/apple-begins-shifting-iphone-17-production-in-india-cooks-china-optimism-and-more-this-week-in-apple?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Apple Begins Shifting iPhone 17 Production In India, Cook&#8217;s China Optimism, And More: This Week In Applev</a>
Gates also mentioned the potential for AI to streamline software applications, suggesting that many current applications could be consolidated into comprehensive systems. 
&#8220;You know we&#8217;ll all have an agent that is a utilitarian help you get things done&#8230;your agent can figure out okay which parts of that are important enough to to take your time to understand,&#8221; he said.
Why It Matters: The conversation aligns with ongoing discussions about AI&#8217;s impact on the workforce. In a recent podcast, Gates and Sam Altman, CEO of OpenAI, <a href="https://www.benzinga.com/personal-finance/24/05/39084794/will-ai-take-over-our-jobs-bill-gates-asks-if-ai-can-support-blue-collar-jobs-as-it-is-already-d">explored AI&#8217;s role </a>in technological advancement, particularly in the workforce. Studies indicate that 37% of companies have already replaced staff with AI, with 44% predicting AI-driven layoffs in 2024.
Furthermore, Hoffman has predicted the end of the <a href="https://www.benzinga.com/startups/24/08/40473377/linkedin-co-founder-predicts-the-death-of-9-to-5-jobs-by-2034-how-ai-the-gig-economy-will-reshape-th">traditional 9-to-5 job by 2034</a>, attributing this shift to AI and the gig economy. This transformation offers increased productivity and flexibility but raises concerns about stable employment.
Additionally, billionaire Vinod Khosla has predicted that <a href="https://www.benzinga.com/personal-finance/24/10/41196355/ai-will-do-most-jobs-better-faster-cheaper-silicon-valley-billionaire-vinod-khosla-calls-for-uni">AI will replace</a> most human jobs over the next 25 years. He suggests that AI could perform 80% of all jobs, including those of primary care doctors, salespeople, and engineers, more efficiently than humans.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41705075/jeff-bezos-backed-perplexitys-new-ai-election-hub-promises-real-time-vote-counts-and-candidate-summa?itm_source=parsely-api" target="_blank" rel="noreferrer noopener">Jeff Bezos-Backed Perplexity&#8217;s New AI Election Hub Promises Real-Time Vote Counts And Candidate Summaries</a></li>
</ul>
Disclaimer: This content was partially produced with the help of&nbsp;<a href="https://www.benzinga.com/author/benzinga-neuro" target="_blank" rel="noreferrer noopener">Benzinga Neuro</a>&nbsp;and was reviewed and published by Benzinga editors.
Image via Flickr/ World Economic Forum

Microsoft Co-Founder Bill Gates Says Everyone In Future Will Have A 'Utilitarian AI Agent' That Will Help You At Work

Detroit-based automaker General Motors (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>) said on Monday that it surpassed selling its 300,000th electric vehicle in the U.S. since 2016 in October. 
What Happened: &#8220;We have more great EVs coming soon, like Cadillac's OPTIQ and ESCALADE IQ, ensuring that when you're ready to make the switch to an all-electric vehicle, you won't have to compromise,&#8221; the company said in a statement. &#8220;GM has spent decades advancing EV technology.&#8221;
GM made a battery electric car as far back as late 90s called the EV1 but the program was eventually terminated in 2001. 
Tesla Inc CEO Elon Musk said in June 2023 that if General Motors had made more EV1s, they would have been the leaders in electric vehicles today. "But they didn't, so there was need for Tesla,&#8221; <a href="https://www.benzinga.com/news/23/06/32910764/general-motors-would-have-been-ev-leaders-if-they-made-more-ev1s-says-tesla-ceo-elon-musk">he said</a>.
According to data from automotive research company Kelley Blue Book, Tesla sold 471,374 EVs in the U.S. through the end of the third quarter, exceeding GM&#8217;s EV sales across nearly 8 years.
Why It Matters: In the third quarter, GM became the second best-seller of EVs in the U.S. after Tesla after selling over 32,000 EVs, with the Chevrolet Equinox EV accounting for a majority of the deliveries.
GM had the longest EV lineup in the U.S. among major players including Tesla in the quarter with eight EV models on sale. 
"We are on track to produce and wholesale approximately 200,000 EVs this year and reach variable profit positive in Q4. Our EV momentum is growing," company CFO&nbsp;Paul A Jacobson&nbsp;<a href="https://www.benzinga.com/markets/equities/24/10/41485013/gm-accelerates-its-ev-ambitions-after-a-strong-q3-in-us-powers-it-past-ford-aims-for-200k-wholes">said </a>during the company&#8217;s third-quarter earnings call last month. 
For the third quarter, GM reported better-than-expected<a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41462946/general-motors-strong-q3-earnings-impress-analysts-highlights-turnaround-and-ev-pro" target="_blank" rel="noreferrer noopener"> results</a>.
GM's quarterly adjusted earnings per share of $2.96 beat the street view of $2.43. Quarterly sales of $48.757 billion also beat the analyst consensus estimate of $44.585 billion.
The company also raised 2024 adjusted EPS guidance from $9.50 – $10.50 to $10.00 – $10.50.
Check out more of Benzinga's Future Of Mobility coverage by&nbsp;<a href="https://www.benzinga.com/topic/mobility" target="_blank" rel="noreferrer noopener">following this link.</a>
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/24/11/41708446/tesla-shares-slide-in-pre-market-as-sales-of-elon-musk-led-companys-made-in-china-evs-drop-in-octobe">Tesla Shares Slide In Pre-Market As Sales Of Elon Musk-Led Company&#8217;s Made-In-China EVs Drop In October</a></li>
</ul>
Photo courtesy: GM

TSLA

GM Crosses 300K EV Deliveries In US Since 2016, But It's Still Over 40% Lower Than Tesla's Sales In The First 9 Months Of 2024

Boeing Co.&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) 33,000 International Association of Machinists and Aerospace Workers ratified a groundbreaking four-year contract, achieving a 43.65% compounded wage increase and a $12,000 ratification bonus. 
What Happened:&nbsp;This deal, supported by President Joe Biden and Vice President Kamala Harris&#8216; administration and facilitated by Acting U.S. Secretary of Labor Julie Su, ends a nearly two-month strike across Washington, Oregon, and California.
The contract introduces key benefits, including a 38% wage increase over four years, enhanced retirement contributions, and improved health benefits. 
IAM leaders Jon Holden and Brandon Bryant praised the agreement, calling it a major victory for the middle class and a new standard for aerospace industry workers.
Price Action: Boeing&#8217;s stock closed at $155.07 on Monday, marking a modest gain of 0.31% during regular trading hours. In after-hours trading, the stock saw an additional rise, climbing 0.63%. Year to date, however, Boeing&#8217;s stock has faced a significant decline, down 38.41%, according to&nbsp;<a href="https://pro.benzinga.com/dashboard" target="_blank" rel="noreferrer noopener">data from Benzinga Pro</a>.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41734875/palantirs-ai-gamble-pays-off-as-customer-revenue-from-single-customer-jumps-12x-in-under-8-month">Palantir&#8217;s AI Gamble Pays Off As Customer Revenue From Single Customer Jumps 12x In Under 8 Months — Alex Karp Quips: &#8216;We Should Just Go Home&#8217;</a></li>
</ul>
Image via Flickr
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/topic/Kaustubh-Bagalkote" target="_blank" rel="noreferrer noopener">Kaustubh Bagalkote</a>

Management

Boeing Workers End Seven-Week Strike By Accepting New Contract With Major Pay Increases

Capital Southwest estimates that the proceeds from the offering will be approximately $193.6 million (or approximately $222.7 million if the underwriters exercise their option to purchase additional notes in full), after deducting underwriting discounts and commissions and estimated expenses payable by Capital Southwest. Capital Southwest expects to use the net proceeds from the offering to redeem in full its 4.50% Notes due 2026, to repay a portion of the outstanding indebtedness under its senior secured revolving credit facility with ING Capital LLC, and for general corporate purposes.

CSWC

Capital Southwest Prices $200M 5.125% Convertible Notes Due 2029, Convertible At 12% Premium, Closing Expected November 8

Avista Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AVA#NYSE">AVA</a>) today signed a nonbinding memorandum of understanding with North Plains Connector LLC, a wholly owned entity of Grid United,&nbsp;in the development of the North Plains Connector, an approximately 420-mile high-voltage direct-current (HVDC) transmission line to be constructed with endpoints near&nbsp;Bismarck, North Dakota&nbsp;and&nbsp;Colstrip, Montana. The parties will now work to finalize definitive agreements regarding Avista's participation, which is expected to involve a 10% ownership share of the project.
Under the terms of the memorandum of understanding, North Plains Connector LLC will continue to fund the development of North Plains Connector. Avista would invest when the project is operational.

Reported Earlier, Avista Enters North Plains Connector Project With PGE And ALLETE In 3,000 MW East-West Transmission Line

Outlook
The Company is lowering its previously provided EPS guidance for the full year. ADM now expects adjusted earnings per share2 in the range of $4.50 to $5.00 for the full year 2024, based on trends in ADM's performance to date, legislative and regulatory policy uncertainties, and ongoing headwinds from slower market demand and internal operational challenges.

Reported Earlier, ADM Lowered Its 2024 Adj. EPS Guidance To $4.50-$5.00 (Prior $5.25-$6.25) Vs. $5.23 Est.

Meta Platforms Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) announced it will make its open-source Llama artificial intelligence models available to U.S. government agencies working on national security and defense applications, marking a significant expansion of the <a href="https://www.benzinga.com/news/24/11/41734318/mark-zuckerbergs-nuclear-powered-ai-ambitions-at-meta-stung-by-rare-bees">technology&#8217;s authorized use cases</a>.
The social media giant is partnering with major government contractors and technology firms including Amazon.com Inc.&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) Amazon Web Services, Lockheed Martin Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), Oracle Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ORCL#NYSE">ORCL</a>), and Palantir Technologies Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) to implement these AI models across various defense initiatives.
&#8220;As an American company, and one that owes its success in no small part to the entrepreneurial spirit and democratic values the United States upholds, Meta wants to play its part to support the safety, security and economic prosperity of America – and of its closest allies too,&#8221; said Nick Clegg, President of Global Affairs at Meta.
Several contractors have already begun implementing Llama in their operations:
<ul>
<li>Oracle is using the technology to improve aircraft maintenance by helping technicians diagnose problems more quickly</li>
<li>Scale AI is fine-tuning the model for national security missions and identifying potential vulnerabilities</li>
<li>Lockheed Martin has integrated Llama into its AI Factory for code generation and data analysis</li>
<li>Amazon Web Services and Microsoft Azure are hosting the models on secure cloud platforms for sensitive government data</li>
</ul>
See Also: <a href="https://www.benzinga.com/markets/equities/24/11/41734875/palantirs-ai-gamble-pays-off-as-customer-revenue-from-single-customer-jumps-12x-in-under-8-month">Palantir&#8217;s AI Gamble Pays Off As Customer Revenue From Single Customer Jumps 12x In Under 8 Months — Alex Karp Quips: &#8216;We Should Just Go Home&#8217;</a>
Why It Matters: Meta emphasized that making Llama available for defense applications aligns with U.S. interests in the global AI race, particularly as nations like China invest heavily in <a href="https://www.benzinga.com/top-stories/24/11/41718416/exclusive-top-20-most-searched-tickers-on-benzinga-pro-in-october-2024-where-do-tesla-nvidia-apple-d">developing their own open-source models</a>.
The company noted that large language models can support various aspects of national security, including streamlining logistics, tracking terrorist financing, and strengthening cyber defenses.
Beyond military applications, Meta highlighted broader public sector benefits, with Deloitte implementing Llama-based solutions for government agencies and nonprofits to improve public service delivery in areas such as education and energy.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41734887/cathie-woods-latest-shake-up-dumps-palantir-and-jack-dorseys-block-along-with-tesla-buys-amazon-">Cathie Wood&#8217;s Latest Shake-up: Dumps Palantir And Jack Dorsey&#8217;s Block Along With Tesla, Buys Amazon And Meta</a></li>
</ul>
Image Via Shutterstock 
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Global

MSFT

ORCL

PLTR

Meta, Amazon, Microsoft Partner On Defense AI Initiative

PolitiFi tokens themed around Donald Trump and Kamala Harris were getting dumped ahead of the Tuesday presidential elections.
What happened: Maga, the largest Trump-inspired coin, dropped 0.5% over the last 24 hours, while Maga Hat crashed over 16% in this period, <a href="https://www.coingecko.com/en/categories/politifi">according </a>to CoinGecko.
Doland Tremp, parodying the former president's name, also tanked over 6%.&nbsp;
Meanwhile, coins mimicking Vice President Kamala Harris weren't spared either, with Kamala Horris, the largest of all Harris-themed tokens in terms of market cap, slipping 9%.&nbsp;
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Gains +/-</td>
<td>Price (Recorded at 11:50 p.m. EDT)</td>
</tr>
<tr>
<td>Maga (TRUMP)</td>
<td>-0.5%</td>
<td>$3.45</td>
</tr>
<tr>
<td>Maga Hat (MAGA)</td>
<td>-16.6%</td>
<td>$0.0001772</td>
</tr>
<tr>
<td>Doland Tremp (TREMP)</td>
<td>-6.4%</td>
<td>$0.2942</td>
</tr>
<tr>
<td>Kamala Horris (KAMA)</td>
<td>-9.6%</td>
<td>$0.0123</td>
</tr>
<tr>
<td>Kumala Herris (MAWA)</td>
<td>-0.6%</td>
<td>$0.003158</td>
</tr>
</tbody>
</table>
</figure>
That said, on a weekly timeframe, KAMA was the clear winner, soaring 58% while most Trump-themed tokens bled heavily.
PolitiFi tokens have been a rage this election year. As the name suggests, these tokens incorporate political themes and campaigns into the cryptocurrency realm.&nbsp;
TRUMP, rooted in Trump's "Make America Great Again" movement, has been the biggest beneficiary, surging an astounding 1171% year-to-date. KAMA, on the other hand, has fallen 62% this year.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41734728/polymarket-whale-dumps-3m-bet-on-trump-after-legendary-trader-advises-caution-recommend-ag">Polymarket Whale Dumps $3M Bet On Trump After Legendary Trader Advises Caution: &#8216;Recommend Against Leverage And Reckless Gambling&#8217;</a>
Why It Matters: These moves come as both presidential candidates gear up for the ultimate fight on Tuesday.
Betting platforms like Polymarket and Kalshi are <a href="https://polymarket.com/">leaning </a>toward a Trump win, though the GOP nominee's odds fell drastically over the weekend.
Election polls, however, painted a tighter race, with a new Emerson College election poll <a href="https://www.benzinga.com/general/politics/24/11/41728436/trump-vs-harris-2024-election-deadlocked-final-emerson-poll-shows-one-candidate-with-small-edge-">showing the two candidates</a> deadlocked at 49%.&nbsp;
A new Morning Consult poll of likely voters showed <a href="https://www.benzinga.com/general/politics/24/11/41733">Harris maintaining a slender two-point lead</a> over Trump.
Photo Courtesy: Shutterstock.com
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41735471/coinbase-ceo-brian-armstrong-criticizes-regulatory-overreach-nothing-to-capture-in-small-g">Coinbase CEO Brian Armstrong Criticizes Regulatory Overreach: &#8216;Nothing To Capture In Small Government&#8217;</a></li>
</ul>

Politics

Trump, Harris-Inspired Cryptos Crack Ahead Of Election Day—Coin Parodying Vice President Still Up Over 50% This Week

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Pre-market stock movers are a great way to start the week as we check out all of the biggest news moving shares on Monday!



Moving stocks this morning are a settlement agreement, Elon Musk&rsquo;s trip to China, a delisting update and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Inno (NYSEARCA:<a href="https://investorplace.com/stock-quotes/inno-stock-quote/">INNO</a>) stock is rocketing more than 58% alongside heavy pre-market trading.</li>



<li>Koninklijke Philips (NYSE:<a href="https://investorplace.com/stock-quotes/phg-stock-quote/">PHG</a>) shares are soaring over 42% after <a href="https://www.cnbc.com/2024/04/29/philips-shares-rocket-33percent-as-firm-settles-us-respiratory-device-case.html">reaching a recall settlement</a>.</li>



<li>XTL Biopharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/xtlb-stock-quote/">XTLB</a>) stock is surging more than 22% without any clear news this morning.</li>



<li>IGC Pharma (NYSEMKT:<a href="https://investorplace.com/stock-quotes/igc-stock-quote/">IGC</a>) shares are gaining over 19% with strong early morning trading.</li>



<li>Prime Medicine (NASDAQ:<a href="https://investorplace.com/stock-quotes/prme-stock-quote/">PRME</a>) stock is rising more than 19% despite a lack of news today.</li>



<li>GraniteShares 2x Long TSLA Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tslr-stock-quote/">TSLR</a>) shares are increasing over 19% after <a href="https://www.bloomberg.com/news/articles/2024-04-29/tesla-clears-key-china-fsd-hurdle-with-baidu-mapping-deal">Elon Musk left China</a> with backing for Tesla&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsla-stock-quote/">TSLA</a>) self-driving software.</li>



<li>Direxion Daily TSLA Bull 2X Shares (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsll-stock-quote/">TSLL</a>) stock is also heading more than 17% higher alongside the China news.</li>



<li>T-REX 2X Long Tesla Daily Target ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tslt-stock-quote/">TSLT</a>) shares are likewise climbing over 17% with the China visit.</li>



<li>Akanda (NASDAQ:<a href="https://investorplace.com/stock-quotes/akan-stock-quote/">AKAN</a>) stock is jumping more than 16% on Monday morning.</li>



<li>GlucoTrack (NASDAQ:<a href="https://investorplace.com/stock-quotes/gctk-stock-quote/">GCTK</a>) shares are up close to 16% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Bakkt (NYSE:<a href="https://investorplace.com/stock-quotes/bkkt-stock-quote/">BKKT</a>) stock is crashing over 92% following a <a href="https://www.nasdaq.com/press-release/bakkt-announces-reverse-stock-split-2024-04-23">reverse stock split on Friday</a>.</li>



<li>Marex (NASDAQ:<a href="https://investorplace.com/stock-quotes/mrx-stock-quote/">MRX</a>) shares are plummeting 60% following its <a href="https://www.marex.com/news/2024/04/marex-group-plc-announces-pricing-of-initial-public-offering/">initial public offering (IPO)</a>.</li>



<li>Clever Leaves (NASDAQ:<a href="https://investorplace.com/stock-quotes/clvr-stock-quote/">CLVR</a>) stock is diving more than 58% on <a href="https://www.nasdaq.com/press-release/clever-leaves-announces-voluntary-delisting-and-sec-deregistration-2024-04-26">voluntary delisting plans</a>.</li>



<li>Addex Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/adxn-stock-quote/">ADXN</a>) shares are taking an over 54% beating on a <a href="https://www.nasdaq.com/press-release/addex-provides-update-on-adx71149-phase-2-epilepsy-study-2024-04-29-0">Phase 2 clinical trial update</a>.</li>



<li>GraniteShares 2x Short TSLA Daily ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tsdd-stock-quote/">TSDD</a>) stock is tumbling more than 18% with Tesla&rsquo;s recent rally.</li>



<li>iSun (NASDAQ:<a href="https://investorplace.com/stock-quotes/isun-stock-quote/">ISUN</a>) shares are sliding over 17% on Monday morning.</li>



<li>T-Rex 2X Inverse Tesla Daily Target ETF (NASDAQ:<a href="https://investorplace.com/stock-quotes/tslz-stock-quote/">TSLZ</a>) stock is dropping more than 17% alongside Tesla&rsquo;s gains.</li>



<li>Boqii (NYSEMKT:<a href="https://investorplace.com/stock-quotes/bq-stock-quote/">BQ</a>) shares are falling over 16% without any apparent news this morning.</li>



<li>Nuzee (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuze-stock-quote/">NUZE</a>) stock is decreasing more than 14% after a Friday rally.</li>



<li>Nature Wood (NASDAQ:<a href="https://investorplace.com/stock-quotes/nwgl-stock-quote/">NWGL</a>) shares close out our pre-market stock movers down over 14 with no clear news to report.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-april-29th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd. has successfully concluded its Extraordinary G...

XTL Biopharmaceuticals Shareholder Meeting Outcomes

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!



Moving stocks this morning are earnings reports, an acquisition deal, a delisting notice and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Tevogen Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/tvgn-stock-quote/">TVGN</a>) stock is rocketing more than 71% after announcing <a href="https://www.nasdaq.com/press-release/tevogen-bio-announces-up-to-%2450-million-in-financing-to-further-advance-operational">$50 million in additional financing</a>.</li>



<li>AC Immune (NASDAQ:<a href="https://investorplace.com/stock-quotes/aciu-stock-quote/">ACIU</a>) shares are soaring over 48% alongside its <a href="https://www.nasdaq.com/press-release/ac-immune-reports-first-quarter-2024-financial-results-and-provides-a-corporate">Q1 2024 earnings report</a>.</li>



<li>Nauticus Robotics (NASDAQ:<a href="https://investorplace.com/stock-quotes/kitt-stock-quote/">KITT</a>) stock is surging more than 31% with heavy pre-market trading.</li>



<li>Dynatronics (NASDAQ:<a href="https://investorplace.com/stock-quotes/dynt-stock-quote/">DYNT</a>) shares are gaining over 21% without any clear news this morning.</li>



<li>GameStop (NYSE:<a href="https://investorplace.com/stock-quotes/gme-stock-quote/">GME</a>) stock is rising more than 19% with the <a href="https://www.marketwatch.com/story/roaring-kitty-is-back-and-gamestop-stock-is-rallying-the-company-still-is-struggling-to-make-money-ca4607c3">return of Roaring Kitty</a>.</li>



<li>XTL Biopharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/xtlb-stock-quote/">XTLB</a>) shares are increasing over 19% despite a lack of news today.</li>



<li>JanOne (NASDAQ:<a href="https://investorplace.com/stock-quotes/jan-stock-quote/">JAN</a>) stock is climbing more than 16% on plans to <a href="https://www.prnewswire.com/news-releases/janone-to-acquire-alt-5-sigma-inc-a-leading-next-generation-blockchain-financial-technology-provider-302142674.html">acquire Alt 5 Sigma</a>.</li>



<li>Fulcrum Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/fulc-stock-quote/">FULC</a>) shares are climbing over 16% on <a href="https://www.nasdaq.com/press-release/fulcrum-therapeutics-enters-into-a-collaboration-and-license-agreement-with-sanofi">a collaboration agreement</a> with Sanofi&nbsp;(NASDAQ:<a href="https://investorplace.com/stock-quotes/sny-stock-quote/">SNY</a>)</li>



<li>Plutonian Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/pltn-stock-quote/">PLTN</a>) stock is jumping more than 15% this morning.</li>



<li>Dermata Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/drma-stock-quote/">DRMA</a>) shares are up over 14% on Monday.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>AEye (NASDAQ:<a href="https://investorplace.com/stock-quotes/lidr-stock-quote/">LIDR</a>) stock is diving close to 14% <a href="https://investorplace.com/2024/05/why-is-aeye-lidr-stock-up-38-today/">following a Friday rally</a>.</li>



<li>Safe &amp; Green Development (NASDAQ:<a href="https://investorplace.com/stock-quotes/sgd-stock-quote/">SGD</a>) shares are tumbling about 13% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318311138&amp;type=PDF&amp;symbol=SGD&amp;cdn=507b0bfaecfda3ee7d6769c0869f5747&amp;companyName=Safe+and+Green+Development+Corporation&amp;formType=D&amp;formDescription=Notice+of+Exempt+Offering+of+Securities&amp;dateFiled=2024-05-10">Notice of Exempt Offering of Securities</a> filing to the Securities and Exchange Commission (SEC).</li>



<li>TransCode Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/rnaz-stock-quote/">RNAZ</a>) stock is taking a more than 12% beating alongside plans for its <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318310991&amp;type=PDF&amp;symbol=RNAZ&amp;cdn=43164c7cc1aa0080fb04a692a6a78bd2&amp;companyName=TransCode+Therapeutics+Inc.&amp;formType=PRE+14A&amp;formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&amp;dateFiled=2024-05-10">annual shareholder meeting</a>.</li>



<li>Visionary (NASDAQ:<a href="https://investorplace.com/stock-quotes/gv-stock-quote/">GV</a>) shares are sliding over 11% following a similar rally on the prior trading day.</li>



<li>Notable Labs (NASDAQ:<a href="https://investorplace.com/stock-quotes/ntbl-stock-quote/">NTBL</a>) stock is dropping more than 11% without any apparent news this morning.</li>



<li>Power REIT (NYSEMKT:<a href="https://investorplace.com/stock-quotes/pw-stock-quote/">PW</a>) shares are falling over 10% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318310902&amp;type=PDF&amp;symbol=PW&amp;cdn=11f58b2db1a9e1bae7887bdcbd213c86&amp;companyName=Power+REIT+%28MD%29&amp;formType=10-Q&amp;formDescription=General+form+for+quarterly+reports+under+Section+13+or+15%28d%29&amp;dateFiled=2024-05-10">rallying Friday on earnings</a>.</li>



<li>Cyngn (NASDAQ:<a href="https://investorplace.com/stock-quotes/cyn-stock-quote/">CYN</a>) stock is decreasing more than 10% with <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318311286&amp;type=PDF&amp;symbol=CYN&amp;cdn=ed67470a33a490d78ff90c97e3b68660&amp;companyName=Cyngn+Inc.&amp;formType=PRE+14A&amp;formDescription=Preliminary+proxy+statement+providing+notification+matters+to+be+brought+to+a+vote&amp;dateFiled=2024-05-10">shareholder meeting plans</a>.</li>



<li>Vitesse Energy (NYSE:<a href="https://investorplace.com/stock-quotes/vts-stock-quote/">VTS</a>) shares are slipping over 10% on Monday.</li>



<li>AYRO (NASDAQ:<a href="https://investorplace.com/stock-quotes/ayro-stock-quote/">AYRO</a>) stock is dipping more than 9% this morning.</li>



<li>Heart Test Laboratories (NASDAQ:<a href="https://investorplace.com/stock-quotes/hscs-stock-quote/">HSCS</a>) shares close out our pre-market stock movers down over 9% <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318310504&amp;type=PDF&amp;symbol=HSCS&amp;cdn=520cd089afcc06b6a1b1e5f350c05d40&amp;companyName=Heart+Test+Laboratories+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-05-10">with a delisting notice</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/05/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-may-13th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd., a clinical-stage biopharmaceutical company, h...

XTL Biopharmaceuticals Expands Portfolio Amidst Profitable Quarter

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd. is set to acquire 100% of the issued and outst...

XTL Biopharmaceuticals Acquires SOCIAL PROXY LTD.

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd. is set to hold its Annual and Extraordinary Ge...

XTL Biopharmaceuticals Announces Upcoming Shareholder Meeting

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
We have all of the biggest pre-market stock movers that traders will want to read about on Monday morning!



Moving stocks this morning an investor update, clinical trial news, a private offering and more.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>Scinai Immunotherapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/scni-stock-quote/">SCNI</a>) stock is rocketing more than 69% alongside heavy pre-market trading.</li>



<li>Schmid Group (NASDAQ:<a href="https://investorplace.com/stock-quotes/shmd-stock-quote/">SHMD</a>) shares are soaring 40% without any clear news this morning.</li>



<li>ENDRA Life Sciences (NASDAQ:<a href="https://investorplace.com/stock-quotes/ndra-stock-quote/">NDRA</a>) stock is surging over 36% alongside an <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318395592&amp;type=PDF&amp;symbol=NDRA&amp;cdn=4506ae3b1a739822361489bedc53ef84&amp;companyName=ENDRA+Life+Sciences+Inc.&amp;formType=SC+13G&amp;formDescription=Statement+of+acquisition+of+beneficial+ownership+by+individuals&amp;dateFiled=2024-06-14">investor stake update</a>.</li>



<li>Maxeon Solar Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/maxn-stock-quote/">MAXN</a>) shares are rising more than 21% with strong early morning trading.</li>



<li>Srivaru (NASDAQ:<a href="https://investorplace.com/stock-quotes/svmh-stock-quote/">SVMH</a>) stock is increasing over 18% as it continues to <a href="https://investorplace.com/2024/06/why-is-srivaru-svmh-stock-up-122-today/">rally on e-bike news</a>.</li>



<li>Nurix Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/nrix-stock-quote/">NRIX</a>) shares are gaining 17% on <a href="https://www.marketwatch.com/story/nurix-therapeutics-shares-rise-on-positive-leukemia-drug-results-66b9d524?mod=investing">positive drug results</a>.</li>



<li>Icecure Medical (NASDAQ:<a href="https://investorplace.com/stock-quotes/iccm-stock-quote/">ICCM</a>) stock is getting a 14% boost with it still rallying on <a href="https://www.nasdaq.com/press-release/positive-data-icecures-kidney-cancer-clinical-study-presented-interventional">kidney cancer study data</a>.</li>



<li>Kineta (NASDAQ:<a href="https://investorplace.com/stock-quotes/ka-stock-quote/">KA</a>) shares are heading more than 13% higher with heavy trading today.</li>



<li>XTL Biopharmaceuticals (NASDAQ:<a href="https://investorplace.com/stock-quotes/xtlb-stock-quote/">XTLB</a>) stock is jumping over 12% this morning.</li>



<li>Conn&rsquo;s (NASDAQ:<a href="https://investorplace.com/stock-quotes/conn-stock-quote/">CONN</a>) shares are up more than 11% today.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Kaival Brands Innovations (NASDAQ:<a href="https://investorplace.com/stock-quotes/kavl-stock-quote/">KAVL</a>) stock is plummeting more than 35% after a massive rally on Friday.</li>



<li>Sonim Technologies (NASDAQ:<a href="https://investorplace.com/stock-quotes/sonm-stock-quote/">SONM</a>) shares are diving over 25% this morning.</li>



<li>AMC Networks (NASDAQ:<a href="https://investorplace.com/stock-quotes/amcx-stock-quote/">AMCX</a>) stock is tumbling more than 23% after <a href="https://www.nasdaq.com/press-release/amc-networks-inc-announces-private-offering-125-million-convertible-senior-notes-2024">announcing a private offering</a>.</li>



<li>Bluejay Diagnostics (NASDAQ:<a href="https://investorplace.com/stock-quotes/bjdx-stock-quote/">BJDX</a>) shares are taking an over 17% beating despite a lack of news.</li>



<li>Northann (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ncl-stock-quote/">NCL</a>) stock is falling close to 14% without any news to report.</li>



<li>Zapp Electric Vehicles (NASDAQ:<a href="https://investorplace.com/stock-quotes/zapp-stock-quote/">ZAPP</a>) shares are dropping more than 13% as it <a href="https://investorplace.com/2024/06/why-is-zapp-electric-vehicles-zapp-stock-up-173-today/">comes off a rally last week</a>.</li>



<li>Aptevo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/apvo-stock-quote/">APVO</a>) stock is decreasing over 13% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318396271&amp;type=PDF&amp;symbol=APVO&amp;cdn=21e6c068c48621c307f0f74bc8553007&amp;companyName=Aptevo+Therapeutics+Inc.&amp;formType=S-1&amp;formDescription=Registration+statement+under+Securities+Act+of+1933&amp;dateFiled=2024-06-14">proposed public offering</a>.</li>



<li>Feutune Light Acquisition (NASDAQ:<a href="https://investorplace.com/stock-quotes/flfv-stock-quote/">FLFV</a>) shares are slipping almost 12% on Monday.</li>



<li>Volcon (NASDAQ:<a href="https://investorplace.com/stock-quotes/vlcn-stock-quote/">VLCN</a>) stock is dipping more than 11% on <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318396398&amp;type=PDF&amp;symbol=VLCN&amp;cdn=980b1d9c3f018f25ac11de4d0e102b66&amp;companyName=Volcon+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-06-14">a delisting notice</a>.</li>



<li>Holdco Nuvo (NASDAQ:<a href="https://investorplace.com/stock-quotes/nuvo-stock-quote/">NUVO</a>) shares close out our pre-market stock movers down over 11% today.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/06/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-monday-june-17th/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd. successfully held its Annual and Extraordinary...

XTL Biopharmaceuticals Announces Shareholder Meeting Outcomes

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd. has successfully acquired The Social Proxy Ltd...

XTL Biopharmaceuticals Expands with AI Company Acquisition

XTL Biopharmaceuticals Ltd. Sponsored ADR (XTLB) has released an update. XTL Biopharmaceuticals Ltd., a company known for its intellectual property...

XTL Biopharmaceuticals Faces Financial Dispute After Acquisition

ACIU

ADXN

AKAN

AMCX

APVO

AYRO

BJDX

BKKT

CLVR

CONN

DRMA

DYNT

FLFV

FULC

GCTK

HSCS

ICCM

INNO

ISUN

KAVL

KITT

LIDR

MAXN

NDRA

NRIX

NTBL

NUVO

NUZE

NWGL

PLTN

PRME

RNAZ

SCNI

SHMD

SONM

SVMH

TSDD

TSLL

TSLR

TSLT

TSLZ

TVGN

VLCN

XTLB

ZAPP

Press Releases

XTL To Aquire The Social Proxy

XTL Entered Definitive Agreement to Acquire The Social Proxy

XTL Completed the Acquisition of The Social Proxy and a Private Placement of $1.5 Million

Market Insight: Power Struggle Arises at XTL Biopharmaceuticals: Court Documents Reveal 'The Social Proxy' Founders Fear Collapse Amidst Refusal for Cash Infusion (NASDAQ: XTLB)

Comments

XTL Biopharmaceuticals

Interés en corto

XTL Biopharmaceuticals (NASDAQ:XTLB) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL